Comparison the effect of Shirvan herbal ointment and glucantim drug on the cutaneous leshmaniasis wounds.
Phase 3
- Conditions
- eishmaniasis.Body mass index (BMI) pediatric, 85th percentile to less than 95th percentile for ageZ68.53
- Registration Number
- IRCT20230621058552N1
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Confirmed cases of urban leishmaniasis.
Informed consent signed
The diameter of the lesion < 2 cm.
Lesions only in hands and feet.
Exclusion Criteria
Pregnant or lactating women,
Cardiovascular patients,
Lesions on joints and cartilage,
The diameter of the lesions> 2 cm,
Illness period of more than 8 weeks,
Sperotrichoid and chronic lesions,
Using any type of treatment for leishmaniasis in the last month.
Participation in any type of project in the last 2 months
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method At each follow-up, the size of erythema, induration, ulceration and scar (largest diameter times its perpendicular diameter in milliliters) will be recorded. Evaluation of clinical recovery based on the complete re-epithelialization of the lesions as the main measure of treatment effect is performed in the last injection session and the follow-up period (1, 4 weeks and 6 months) on each of the treated lesions. Timepoint: The measurement of the lesion is at the beginning of the study (before the start of the intervention) and 1, 4 weeks and 6 months after the start of taking Shirvan herbal ointment and glucantim medicine. Method of measurement: The lesion surface will be measured using caliper software.
- Secondary Outcome Measures
Name Time Method